Zoetis (WBO:ZOTS) Long-Term Debt : €6,037 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Zoetis Long-Term Debt?

Zoetis's Long-Term Debt for the quarter that ended in Mar. 2024 was €6,037 Mil.

Zoetis's quarterly Long-Term Debt declined from Sep. 2023 (€6,139 Mil) to Dec. 2023 (€6,019 Mil) but then increased from Dec. 2023 (€6,019 Mil) to Mar. 2024 (€6,037 Mil).

Zoetis's annual Long-Term Debt increased from Dec. 2021 (€5,834 Mil) to Dec. 2022 (€6,185 Mil) but then declined from Dec. 2022 (€6,185 Mil) to Dec. 2023 (€6,019 Mil).

Zoetis Long-Term Debt Historical Data

The historical data trend for Zoetis's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zoetis Long-Term Debt Chart

Zoetis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

5,352.30

5,421.09

5,833.92

6,185.09

6,019.19

Zoetis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															6,126.11	6,050.27	6,139.22	6,019.19	6,037.04

Zoetis (WBO:ZOTS) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Zoetis Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Zoetis's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Zoetis (WBO:ZOTS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zoetis Inc (WBO:ZOTS) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

ZTS:USA ZTS:Mexico 1ZTS:Italy ZOE:Germany Z1TS34:Brazil

Address

10 Sylvan Way, Parsippany, NJ, USA, 07054

Website

https://www.zoetis.com

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Zoetis (WBO:ZOTS) Headlines

No Headlines